Berkshire Innovation Center’s Post

Name: Berkshire Innovation Center on LinkedIn: #medtech #innovation #medicaldevice #diabetes #diabetesmanagement
Uploaded: 2024-02-05T15:25:39.545Z
Duration: 4 min 40 s
Channel: Berkshire Innovation Center
Description: Learn about MacFarlane Medical by checking out this video from our "Meet the Stage 2 Accelerator" firms event at the BIC. #Medtech #Innovation #MedicalDevice #Diabetes #DiabetesManagement Connor MacFarlane

Berkshire Innovation Center

2,604 followers

9mo Edited

Learn about MacFarlane Medical by checking out this video from our "Meet the Stage 2 Accelerator" firms event at the BIC. #Medtech #Innovation #MedicalDevice #Diabetes #DiabetesManagement Connor MacFarlane

3 Comments

Transcript

My name is Connor McFarland. I'm the founder and CEO of McFarland Medical. So McFarland Medical is working to simplify insulin delivery for people whose lives are being unnecessarily burdened by the difficulties of diabetes management. So what? What do I mean by that? So the problem is, people with diabetes have to take external insulin in order to manage their blood sugar levels. Traditionally, this was accomplished through multiple daily injections using a syringe and a glass vial of insulin. But due to how difficult and inaccurate these devices are to use, most patients are now transitioning to more modern insulin pens and pen needles. But the main problem still remains. Taking multiple injections every single day is painful, time-consuming, and wasteful. And so to solve that problem, insulin pumps were developed. Traditional pumps work by having a small, flexible cannula that stays inserted in your skin and running along tube back to a battery operated pump that delivers insulin continuously throughout the day. Because they can be worn for up to three days at a time, they're able to eliminate the frequent injections that are associated with multiple daily injections, but of course they add their own. Most of new problems not only are they extremely expensive and very difficult to use, making them inaccessible to many populations, they're also prone to glitches and failures that often require replacement. The the long tube that connects the pump to the patient's body is a serious snagging hazard. You know it's all too common a story that someone walked just a little too close to a doorknob and they're pump was ripped right off their body. The only pumps that don't have this tube are patch style pumps and the way they got rid of it by taking that phone sized. Trump and attaching it directly to your skin. The time, cost and effort required to successfully use these devices is truly prohibitive to many patients that are just looking for a simple way to manage their health. And I would know I'm one of them. When I was 16, I was diagnosed with type one diabetes and it changed my life. You know, I've faced a lot of the problems that I just listed, but I decided that we could do better. And with that, the idea that spurred McFarland Medical was born. So introducing the ID. So our device is able to bridge the gap between multiple daily injections. And pumping by taking the best aspects of both and leaving behind the drawbacks. So we use the same shot reducing technology as an insulin pump where that small flexible tube stays inserted in your skin. But instead of running a long tube all the way back to your battery operated pump, we have a small housing that can interface directly with the insulin pens that are in use today. Using the device is super simple. The patient prepares their pen, inserts the tip into the open port on their skin and presses down on the plunger delivering the insulin immediately. There's no sharps disposal required in this process. Simply remove the pen, recap both devices, and you're done. When the port is closed, it creates a waterproof seal that protects the medicine delivery channel from contamination, and the port itself is made of a durable thermoplastic. It's been designed to stay adhered to the patient's body for up to three days at a time, which is on par with most approved infusion sets, and it is over 10 times smaller than the leading patch pump. This unique combination of features is what allows our users to participate in any and every activity in daily life without ever being hindered by their insulin delivery device. And so you might be wondering why now you know technology is getting more and more advanced and that has allowed some patients to achieve really great control over their blood glucose levels. But more and more complicated technology has also led to more and more problems. In the last year alone, all three of the major pump manufacturers have been forced to issue recalls due to safety concerns over their devices. These concerns ranged from incorrect dosing all the way to batteries Catching Fire and exploding and so obviously. That's not acceptable. Additionally, with the shift from syringes to pens, insulin pens have seen improvements in recent years, culminating in the development of what's known as smart pens. And so these are insulin pens that are able to do the same calculations and data logging as an advanced insulin pump, but without the pump. Unfortunately, these pens still require the use of a traditional pen needle to Pierce the skin and deliver insulin. Unless we combine them with our device where we could create a disconnected closed loop system. My vision for the future of diabetes care is to eliminate frequent injections and complicated devices within five years, and I can't imagine a better place to be to try and accomplish this goal. So thank you all for listen. Thank you.

Connor MacFarlane

Process Engineer @ CRB | Chemical Engineering - UMass Amherst | Entrepreneurship Enthusiast

9mo

Thank you for sharing! It is always great to spend time out at the BIC with their fantastic team and ecosystem.

1 Reaction

Robert Sims

SVP Retail Services

9mo

Well done Connor!

1 Reaction

See more comments

To view or add a comment, sign in

More Relevant Posts

Hubert R.

Biotech Medtech eHealth | Corporate Strategy Management | Executive Marketing & Sales | Matrix Org. & Start-up
6mo
Report this post
🌟 A heartfelt thank you to the Biopôle Lausanne team for the remarkable event yesterday, co-organized with digitalswitzerland, focusing on the unique challenges digital health startups and scale-ups encounter during the crucial transition from design to deployment. Yesterday's event illuminated the path for many of us in the digital health sector. Tigen Pharma's presentation was a highlight, brilliantly outlining their comprehensive framework. They covered everything from equipment setup, data collection strategies, to the integration of digital twins and business applications. This structured approach ensures consistency across platforms used in CGT autologous clinical trials, which is nothing short of essential. The panel discussion was equally enlightening, exploring critical topics like patient centricity, intellectual property rights, IT infrastructure, and MDR standards. Each panellist brought profound insights that underscored the importance of maintaining focus on these areas as we move from the design and development phase into clinical trials. 🔍 The takeaways from this event are invaluable as we strive to navigate the complex landscape of digital health innovation. Let's keep these lessons in mind and continue to push the boundaries of what's possible in healthcare. 💡 Thank you again to everyone involved for a day full of learning and inspiration! #digitalhealth #innovation #biopôle #digitalswitzerland #healthcaretechnology #clinicaltrials #patientcentricity
1 Comment
Like Comment
To view or add a comment, sign in
François Capel

Innovation Sherpa | Ecosystem Weaver | Life Science and Nutrition
6mo
Report this post
🌟 What an incredible event we had yesterday on navigating "The Medical Device Road-to-Market"! 🌟 A huge thank you to our distinguished speakers from Lymphatica Medtech (Marco Pisano), Euresearch (Irina Sakharova Quitt), Swiss Medtech association (Daniel Delfosse), and F+R services (Mayella Favre) for sharing their invaluable insights! 👏 Here are some personal takeway from the event: 1. Financing Clinical Studies: It's essential to target a large addressable market (>500M USD/year) and gather support from clinical communities and strategic partners. Beyond venture capital, Horizon Europe funding can significantly aid in financing these studies. 2. Regulatory Challenges: The phrase "US innovates," "Asia manufactures," and "EU regulates" highlights the unique landscape. However, EU regulations introduce significant uncertainties regarding time and cost. EU regulators need to understand that patient safety is not just about product safety but encompasses product safety, availability, and innovation! 3. Achieving Reimbursement: Gaining CE certification is just the beginning. The next phase—securing reimbursement—requires navigating a complex process involving a different set of stakeholders. So bringing a medical device to market is a long and challenging journey that demands extensive planning and the engagement of a diverse range of stakeholders at various stages. The event truly underscored that the success of innovation extends well beyond mere technological advancements. Thank you to everyone who participated and made this event a success. Looking forward to more such enriching sessions in the future! #Medtech #Innovation #RoadtoMarket #MedicalDevices #VDtech Innovaud
6 Comments
Like Comment
To view or add a comment, sign in
Mecomed

6,834 followers
9mo Edited
Report this post
Uncover the milestones in #MedTech innovation with Mecomed's 2023 Annual Report, marking a year of creating strategic patient-centric alliances, shaping MedTech #regulations, and a strengthened commitment to #compliance. Our Board of Directors' progressive vision and Secretariat’s hard work have been instrumental in these achievements, underscoring the collaborative nature of our association. The comprehensive insights from all our committees further illustrate the broad spectrum of #Mecomed’s strategic efforts driving patient care forward in the MEA region. Read the full report here: https://bit.ly/3OC3s2Y
Like Comment
To view or add a comment, sign in
Accelerate Associates

172 followers
1mo
Report this post
🚀 Transforming Innovation into Commercial Success 🚀 We're thrilled to share the remarkable success story of SageTech Medical, a testament to the power of strategic innovation. Our latest case study demonstrates how, by starting with an Accelerate early-stage medical technology innovation assessment, SageTech Medical has successfully navigated the complex pathways of commercialisation, transforming an innovative idea into real-world impact. Key Achievements: 🔑Expert Research: Accelerate provided in-depth market insights and strategic guidance tailored to SageTech Medical's specific needs. 🔑Successful Commercialisation: SageTech Medical has successfully launched their cutting-edge technology to safely collect harmful waste anaesthetic gas, providing a pathway for improved sustainability across the global healthcare economy. ▶️Read the case study: https://loom.ly/0FSE6wY This example shows how tailored, strategic insights can drive innovation from concept to market success. If you are looking to unlock the potential of your innovations, connect with us today. Let's explore how our market research support can be a catalyst for your success. #MedicalTechnology #Innovation #MarketResearch #SuccessStory #HealthcareInnovation
Like Comment
To view or add a comment, sign in
Shan Sumeera

Senior Manager at RSM Australia
9mo
Report this post
Explore the rapidly expanding field of Medtech, a thriving industry that plays a crucial role in shaping our economy, enhancing healthcare, and driving innovation. Gain valuable insights by downloading our latest report today.

RSM Australia

39,832 followers
9mo Edited

Medtech is a rapidly growing industry that contributes to our economy, health, and innovation. But how much do you know about it? Download our latest report to learn more 👉 https://bit.ly/4bHHkOs The report features insights by RSM Australia's Jayesh Kapitan, Dr Rita Choueiri, Don Holley, Srdjan Dragutinovic, and Rebecca Barnes, as well as key leaders in the local and international medtech sector. Trajan Scientific and Medical Osteopore (OSX.AX) Mach7 Technologies Specialised Therapeutics #RSMAustralia #Medtech #Healthcare #Innovation
Like Comment
To view or add a comment, sign in
Fabien Pezous

CEO co-founder at Apotech Consulting
8mo
Report this post
📢 Exciting News! 🎉 I’m thrilled to announce that I’ll be attending MedInTechs, the premier medical innovation and technology event. 🗓️ When: March 11th and 12th, 2024 📍 Where: Parc Floral, Paris MedInTechs brings together healthcare professionals, experts in new technologies, and the general public to explore groundbreaking innovations that are shaping the future of healthcare. 🚀 I would be more specifically keen to talk about international registrations, and how best can Apotech Consulting support you in your understanding of international regulations 💡🤝 Learn more and register at MedInTechs. See you there! 👋🏼 #MedInTechs #ukrp #regulatoryaffairs

2 Comments
Like Comment
To view or add a comment, sign in
Medtech Leaders

763 followers
9mo
Report this post
Despite the slowdown in deal-making in 2023, opportunities are on the up as Tier 1 companies increasingly outsource innovation. What is the outlook of top strategics as they form partnerships in 2024? At #MedtechLeaders this April as part of our LSX World Congress 2024, our medtech executive speakers will explore the transformative potential of collaborative alliances, focusing on key topics such as: 🔹 Navigating regulatory challenges through partnerships with Tier 1 manufacturers 🔹 Addressing privacy and data management in collaborative ventures 🔹 Harnessing academic research to achieve market success in partnerships Meet Our Expert Panelists: 🎤 Stuart Hart, MD, MBA, MS, FACOG, FACS, Chief Scientific Officer, Integra LifeSciences 🎤 Ori Hadomi, VP Strategic Initiatives & Partnerships, Medtronic 🎤 Jan Kimpen, Former CMO Philips, Partner, Sanara 🎤 Kathleen Van Vlierberghe, VP Healthcare Solutions & Partnerships EMEA, Boston Scientific Scheduled as our opening keynote 09.10 April 29th, this panel will be kicking off a jam-packed two days of content, partnering, workshops and showcases. Registrations are still open for this event, visit here - https://lnkd.in/esbJsTJ9 - to learn more and secure your spot at our earlybird rates. #medtech #medicaldevices #medicaldevice #lsxwc24 #ml24 #innovation #investing #showcase #lifesciences

LSX MedTech Leaders

informaconnect.com
Like Comment
To view or add a comment, sign in
Jose Cerdan de las Heras, PhD

Digital Health | Telemedicine | Clinical Trials | MedTech Innovator | Entrepreneur
1mo Edited
Report this post
🌟 Earning Your Stars & Stripes – The US Playbook I had the privilege to attend this insightful panel at the LSX Nordic Congress, focusing on scaling healthtech and medtech companies in the US market. A huge thank you to Paula Petcu for introducing me to this event and facilitating my access. Your support made this experience possible! Key takeaways from the panel: -> Philip Siberg warned that entering the US market may cost ten times your initial budget and advised being cautious with sales strategies. -> Martin Bostrup, PhD highlighted that having solid evidence from the EU can significantly expedite market entry in the US. I look forward to collaborating further with him on creating strong evidence in medical affairs. -> @Filip Peters emphasized the importance of building strong connections with the FDA and exploring NIH programs for funding. -> Jørn Emborg reminded us that networking is crucial for success in the US market, stating, “It’s not always about money; it’s about having the right connections.” -> Shilpa Ashok Razdan stressed starting with feasibility studies to build robust data packages for the US. At Erudita.tech, we’re dedicated to streamlining processes in decision-making and regulatory documentation. Our solutions can empower your organization to navigate the complexities of the US market more effectively, expediting systematic reviews and enhancing compliance. If these challenges resonate with your organization, let’s connect! hashtag #LSXNordic #HealthTech #MedTech #USMarket #RegulatoryCompliance #AI #Erudita #Collaboration #DecisionMaking
Like Comment
To view or add a comment, sign in
Psephos Biomedica

1,061 followers
9mo
Report this post
Today, Psephos Biomedica and Science & Engineering Health Technologies Alliance (SEHTA) are holding a Masterclass for the Imperial College London MedTech SuperConnector Cohort on ‘Accessing the NHS and Standards and Regulations Strategy’. Irfan Hassan will be talking on the Standards and Regulations that apply to Health Technologies. If you are looking for advice on regulations that apply to your medical device, contact us at info@psephos.com #regulations #medtech #medicaldevices #healthtech
Like Comment
To view or add a comment, sign in
Haley Schwartz

VP | Advisor | Go-To-Market Expert | Published Author | Fluent in French & English
8mo
Report this post
The conference whirlwind continues! It started with #vive2024, continued with BioscienceLA and #LAMedtechweek, and now onto #lsiusa24! I am very proud to be sponsoring the event this year to support medical device go-to-market strategy. Catalyze Healthcare works with medical device companies and investment firms to launch new medtech innovations efficiently and methodically. If you are interested in learning more, DM me to connect! #medtech #gotomarket #medicaldevices #healthcareinnovation
2 Comments
Like Comment
To view or add a comment, sign in

2,604 followers

View Profile Connect

Berkshire Innovation Center’s Post

Transcript

More Relevant Posts

Explore topics